Large volume reirradiation as salvage therapy for glioblastoma after progression on bevacizumab

By Magnuson William   Ian Robins H.   Mohindra Pranshu   Howard Steven  

Journal of Neuro-Oncology, Vol. 117, Iss. 1, 2014-03 ,pp. : 133-139

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of metronomic chemotherapy with bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy

By Reardon David   Desjardins Annick   Peters Katherine   Gururangan Sridharan   Sampson John   Rich Jeremy   McLendon Roger   Herndon James   Marcello Jennifer   Threatt Stevie   Friedman Allan   Vredenburgh James   Friedman Henry  

Journal of Neuro-Oncology, Vol. 103, Iss. 2, 2011-06 ,pp. : 371-379

Springer Publishing Company

Access to resources Recommend Favorite

Salvage chemotherapy with bevacizumab for recurrent alkylator-refractory anaplastic astrocytoma

By Chamberlain Marc   Johnston Sandra  

Journal of Neuro-Oncology, Vol. 91, Iss. 3, 2009-02 ,pp. : 359-367

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy of temozolomide and bevacizumab for the treatment of leptomeningeal dissemination of recurrent glioblastoma: A case report

By              

Oncology Letters, Vol. 9, Iss. 4, 2015-01 ,pp. : 1885-1888

Spandidos Publications

Access to resources Recommend Favorite

Enigma of a rapid introduction of antiangiogenic therapy with bevacizumab in glioblastoma - a new era in the treatment of malignant brain tumours?

By Henriksson Roger   Bergstrom Per   Johansson Mikael   Sandstrom Maria  

Acta Oncologica, Vol. 48, Iss. 1, 2009-01 ,pp. : 6-8

Informa Healthcare

Access to resources Recommend Favorite